elenbecestat

Eisai Presents Nonclinical Research Results of Elenbecestat at AAIC 2019

Without Significant Effects on Synaptic Function in Brain by Spinal Densitiy Evaluation at Effective Dose to Decrease Amyloid Beta Level…

5 years ago

Latest Data on Eisai’s Alzheimer’s Disease / Dementia Pipeline to be Presented at Alzheimer’s Association International Conference (AAIC) 2018

Thirteen presentations to be given including on Phase II study results of BAN2401 and elenbecestat Tokyo, July 23, 2018: Eisai…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420